Skip to main content

Phenotypes and Genotypes of Apolipoprotein E in Japanese Patients with Late-Onset Sporadic Alzheimer’s Disease, Vascular Dementia, Down’s Syndrome or Parkinson’s Disease

  • Chapter
  • 14 Accesses

Part of the book series: Advances in Behavioral Biology ((ABBI,volume 44))

Abstract

Alzheimer’s disease (AD) is a major cause of dementia in the elderly. Most patients are sporadic and develop the disease after 60 years of age. Senile plaques (SP), neurofibrillary tangles (NFT) and amyloid angiopathies are observed histopathologically and the deposition of β-amyloid protein is postulated to play a crucial role in the development of AD.1 Extensive genetic studies in this late-onset AD have failed to identify any consistent abnormalities in the gene encoding amyloid precursor protein (APP) so far, and the mechanism for deposition of β-amyloid is yet to be determined.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. D.J. Selkoe, The molecular pathology of Alzheimer’s disease, Neuron 6: 487 (1991).

    Google Scholar 

  2. R.W. Mahley, Apolipoprotein E: cholesterol transport protein with expanding role in cell biology, Science 240: 1125 (1988).

    Google Scholar 

  3. Y. Namba, M. Tomonaga, H. Kawasaki, E. Otomo, and K. Ikeda, Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease, Brain Res. 541: 163 (1991).

    Google Scholar 

  4. W.J. Strittmatter, A.M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G.S. Salvesen, and A.D. Roses, Apolipoprotein E: high-avidity binding to ß-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A. 90: 1977 (1993).

    Article  PubMed  CAS  Google Scholar 

  5. M.A. Pericak-Vance, J.L. Bebout, P.C. Gaskell Jr, L.H. Yamaoka, W-Y. Hung, M.J. Alberts, A.P. Walker, R.J. Barlett, C.A. Haynes, K.A. Welsh, N.L. Earl, A. Heyman, C.M. Clark, and A.D. Roses, Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage, Am. J. Hum. Genet. 48: 1034 (1991).

    PubMed  CAS  Google Scholar 

  6. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. St. George-Hyslop, M.A. Pericak-Vance, S.H. Joo, B.L. Rosi, J.F. Gusella, D.R. Crapper-MacLachlan, M.J. Alberts, C. Hulette, B. Crain, D. Goldgraber, and A.D. Roses, Association of apolipoprotein E allele e 4 with late-onset familial and sporadic Alzheimer’s disease, Neurology 43: 1467 (1993).

    Article  PubMed  CAS  Google Scholar 

  7. J. Poirier, J. Davignon, D. Bouthillier, S. Kogan, P. Bertrand, and S. Gauthier, Apolipoprotein E polymorphism and Alzheimer’s disease, Lancet 342: 697 (1993).

    CAS  Google Scholar 

  8. A. Ueki, M. Kawano, Y. Namba, M. Kawakami, and K. Ikeda, A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer’s disease, Neurosci. Lett. (1993) (in press).

    Google Scholar 

  9. American Psychiatric Association, “Diagnostic and Statistical Manual of Mental Disorders” 3rd ed. revised (DSM-III-R), Am. Psychiatric Assoc.,Washington D.C.(1987).

    Google Scholar 

  10. J.P.H. Wade, T.R. Mirsen, V.C. Hachinski, M. Fisman, C. Lau, and H. Merskey, The clinical diagnosis of Alzheimer’s disease, Arch. Neurol. 44: 24 (1987).

    Article  PubMed  CAS  Google Scholar 

  11. V.C. Hachinski, E. Zilhka, G.H. DuBoulay, V.L. MacAllister, J. Marshall, R.W.R. Russell, and L.Symon, Cerebral blood flow in dementia, Arch Neurol. 24 32: 632 (1975).

    Google Scholar 

  12. E. Eto, K. Watanabe, Y. Iwashima, A. Morikawa, E. Oshima, M. Sekiguchi, and K. Ishii, Apolipoprotein E polymorphism and hyperlipidemia in type II diabetes, Diabetes 35: 1374 (1986).

    CAS  Google Scholar 

  13. G. Uterman, Apolipoprotein E polymorphism in health and disease, Am. Heart J. 113: 433 (1987).

    Article  Google Scholar 

  14. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families, Science 24 261: 921 (1993).

    Article  Google Scholar 

  15. D.M. Hallman, E. Boerwinckel, N. Saha, C. Sandholzer, H.J. Menzel, A. Cazar, and G. Uterman, Apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations, Am. J. Hum. Genet. 49: 338 (1991).

    PubMed  CAS  Google Scholar 

  16. A. Karasawa, Recent advances in epidemiology of dementia among elderly, Shinkei Shinpo. (English abstr.) 33: 766 (1989).

    Google Scholar 

  17. D.M.A. Mann, Alzheimer’s disease and Down’s syndrome, Histopathology 13: 125 (1988).

    Article  PubMed  CAS  Google Scholar 

  18. T. Wisniewski, and B. Frangione, Apolipoprotein E: a pathological chaperon protein in patients with cerebral and systemic amyloid, Neurosci. Lett. 135: 235 (1992).

    Article  PubMed  CAS  Google Scholar 

  19. A.M. Saunders, K. Schmader, J.C.S. Breitner, M.D. Benson, W.T.Brown, L. Goldfarb, D. Goldgaber, M.G. Manwaring, M.H. Szymanski, N. McCown, K.Dole, D.E. Schmechel, W.J. Strittmatter, M.A. Pericak-Vance, and A.D. Roses, Apolipoprotein E E 4 allele distributions in late-onset Alzheimer’s disease and in other amyloid-forming diseases, Lancet 342: 710 (1993).

    Article  PubMed  CAS  Google Scholar 

  20. R. Mayeux, Y. Stern, R. Rosenstein, K. Marder, A. Hauser, L. Cote, and S. Fahn, An estimate of the prevalence of dementia in idiopathic Parkinson’s disease, Arch. Neurol. 45: 260 (1988).

    Article  PubMed  CAS  Google Scholar 

  21. A.M. Hakim, and G. Mathieson, Dementia in Parkinson disease: a neuropathologic study, Neurology 29: 1209 (1979).

    Google Scholar 

  22. J.K. Boyles, R.E. Pitas, E. Wilson, R.W. Mahley, and J.M. Taylor, Apolipoprotein E association with astrocyte glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system, J. Clin. Invest. 82: 1501 (1985).

    Article  Google Scholar 

  23. R.E. Pitas, J.K. Boyles, S.H. Lee, D. Foss, and R.W. Mahley, Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein-containing lipoproteins, Biochem. Biophys. Acta 917: 148 (1987).

    Article  CAS  Google Scholar 

  24. M. Murakami, Y. Ushio, Y. Morino, T. Ohta, and Y. Matsukado, Immunohistochemical localization of apolipoprotein E in human glial neoplasms, J. Clin. Invest. 82: 177 (1988).

    Article  CAS  Google Scholar 

  25. G. Stoll, H.W. Mueller, B.D. Trapp, and J.W. Griffin, Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve, Glia 2: 170 (1989).

    CAS  Google Scholar 

  26. J.K. Boyles, C.D. Zoeliner, L.J. Anderson, L.M. Kosik, R.E. Picas, K.H. Weisgraber, D.Y. Hui, R.W. Mahley, P.J. Gebicke-Haerter, M.J. Ignatius, and E.M. Shooter, A role for apolipoprotein E, apolipoprotein A-1, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve, J. Clin. Invest. 83: 1015 (1989).

    Article  PubMed  CAS  Google Scholar 

  27. M.J. Ignatius, P.J. Gebick-Haerter, J.H.P. Skene, J.M. Schilling, K.H. Weisgraber, R.W. Mahley, and E.M. Shooter, Expression of apolipoprotein E during nerve degeneration and regeneration, Proc. Natl. Acad. Sci. U.S.A. 83: 1125 (1986).

    Article  PubMed  CAS  Google Scholar 

  28. G.J. Snipes, C.B. McGuire, J.J. Norden, and J.A. Freeman, Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells, Proc. Natl. Acad. Sci. U.S.A. 83: 1130 (1986).

    Article  PubMed  CAS  Google Scholar 

  29. W.J. Strittmatter, K.H. Weisgraber, D.Y. Huang, Li-Ming Dong, G.S. Salvesen, M. Pericak-Vance, D. Schmechel, A.M. Saunders, D. Goldgaber, and A.D. Roses, Binding of human apolipoprotein E to synthetic amyloid ß peptide: isoform-specific effects and implication for late-onset Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A. 90: 8098 (1993).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ueki, A. et al. (1995). Phenotypes and Genotypes of Apolipoprotein E in Japanese Patients with Late-Onset Sporadic Alzheimer’s Disease, Vascular Dementia, Down’s Syndrome or Parkinson’s Disease. In: Hanin, I., Yoshida, M., Fisher, A. (eds) Alzheimer’s and Parkinson’s Diseases. Advances in Behavioral Biology, vol 44. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9145-7_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9145-7_28

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9147-1

  • Online ISBN: 978-1-4757-9145-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics